I  Coridea

https://coridea.com/





     Office Locations:

315 West 36th Street, 5th Floor
New York, NY 10018
Phone: 212-929-6600
Fax: 888-753-1663

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Coridea is an idea generator, technology incubator and consulting firm that applies established technologies to new targets in the cardio-renal and cardio-pulmonary fields. Since its inception in 2003, Coridea has launched six startup companies including Ardian, CHF Solutions, and Respicardia (formerly, Cardiac Concepts). The $800 MM acquisition of Ardian by Medtronic marked the highest-priced venture capital-backed pre-revenue medical device acquisition to date. With 66 U.S. patents licensed by companies such as Evalve, Zoll Medical, Nephros, and PLC Medical (58 of which have been successfully translated into devices in clinical use or clinical trials); over $150 million in venture capital financing; and the invention of 2011 Edison Award-winning Symplicity Catheter System, Coridea is a leader in medical device innovation.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Howard Levin MD Managing Partner, President, and Chief Scientific Officer
    Mark Gelfand Managin Partner and Cheif Technical Officer
    Zoar Engelman Partner and Vice President, Research and Development

     

    Portfolio companies include:


      Ardian


      EP Sciences


      RenalGuard


     

    Recent News: